Autori: Martin Miguel
| Naslov | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial (Article) |
| Autori | Martin Miguel ... Tomasevic Zorica I ... (broj koautora 34) |
| Info | LANCET ONCOLOGY, (2017), vol. 18 br. 12, str. 1688-1700 |
| Projekat | Wyeth; Pfizer; Puma Biotechnology |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
